Patents by Inventor Aixiang Jiang

Aixiang Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240402183
    Abstract: Spatial analysis methods based on nearest neighbor analysis are provided of specific regions of tissue to describe cancer states and develop biomarkers to predict outcomes. In various embodiments, the spatial analysis methods involve an interaction radius to computationally isolate local interactions and prevent the data from being influenced by cells that are very far away. Thereby, spatial analysis of cancer tissue can be quickly and consistently performed in an automated fashion to focus on tumor-immune cell biology, which occurs at a localized level.
    Type: Application
    Filed: May 31, 2024
    Publication date: December 5, 2024
    Applicants: CEDARS-SINAI MEDICAL CENTER, BC CANCER, part of the Provincial Health Services Authority
    Inventors: Alexander Xu, Akil Merchant, Anthony Colombo, Tomohiro Aoki, Aixiang Jiang, Christian Steidl
  • Patent number: 11692228
    Abstract: The present invention relates to gene expression profiles for B-cell lymphoma. More specifically, the present invention relates to gene expression profiles for diagnosis, prognosis or therapy selection for an aggressive B-cell lymphoma.
    Type: Grant
    Filed: October 15, 2019
    Date of Patent: July 4, 2023
    Assignee: Provincial Health Services Authority
    Inventors: Daisuke Ennishi, Aixiang Jiang, Ryan Morin, David Scott
  • Publication number: 20220002814
    Abstract: The present invention relates to gene expression profiles for B-cell lymphoma. More specifically, the present invention relates to gene expression profiles for diagnosis, prognosis or therapy selection for an aggressive B-cell lymphoma.
    Type: Application
    Filed: October 15, 2019
    Publication date: January 6, 2022
    Inventors: Daisuke ENNISHI, Aixiang JIANG, Ryan MORIN, David SCOTT
  • Publication number: 20110097423
    Abstract: The present invention is drawn to methods of assessing colorectal cancer prognosis by examining the expression of particular genes disregulated in this disease state. Subjects exhibiting disregulation in one or more of these genes will have a higher risk of cancer recurrence and death.
    Type: Application
    Filed: October 21, 2010
    Publication date: April 28, 2011
    Applicant: Vanderbilt University
    Inventors: R. Daniel Beauchamp, Jesse J. Smith, Aixiang Jiang, Yu Shyr, Bing Zhang, Natasha G. Deane